Courage Over Cancer

UT Health San Antonio scientists uncover how some cancers outsmart immune system
FOXM1 protein identified as key driver in immunotherapy resistance, unlocking new therapeutic avenues For years, scientists have found the overexpression of a specific protein called FOXM1 in a wide range of cancers, including ovarian, breast and pediatric cancers. A recent study by scientists at The University of Texas Health Science Center at San Antonio […]
Read more
Dr. Kurmasheva awarded CURE foundation grant for childhood cancer research
A cancer diagnosis is always devastating and is especially overwhelming when the patient is a child. This is why the CURE Childhood Cancer Foundation is on a mission to advance research that will bring an end to childhood cancers. Recently, Raushan Kurmasheva, PhD, assistant professor at the Greehey Children’s Cancer Research Institute and Department of […]
Read more
Cancer ghosting: A silent side effect of survivorship
“Cancer ghosting” is a relatively new term that has gained popularity among people diagnosed with cancer. It refers to the all-too-common phenomenon of receiving a cancer diagnosis and then watching friends and family members “ghost,” or disappear from your life.
Read more
Max and Minnie Tomerlin Voelcker Fund grants UT Health San Antonio $1.25 million to support research from early career investigators
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been awarded $1.25 million by the Max and Minnie Tomerlin Voelcker Fund to support research projects being conducted by the institution’s early career investigators. Voelcker Fund Young Investigator Awards The Voelcker Fund Young Investigator Award will fund each recipient’s […]
Read more
Owens Medical Research Foundation awards UT Health San Antonio investigators $1.5 million to advance Alzheimer’s and cancer research
The William and Ella Owens Medical Research Foundation recently awarded $1.5 million to The University of Texas Health Science Center at San Antonio (UT Health San Antonio) for research projects that address pancreatic cancer, Alzheimer’s disease and childhood cancers. This year, the foundation will fund $250,000 each to six research projects from UT Health […]
Read more
Key DNA complex connected to PARP inhibitor cancer-drug resistance discovered
Scientists at The University of Texas Health Science Center at San Antonio have made one of the most important discoveries to date in the study and treatment of BRCA1-deficient cancers and drug resistance.
Read more